Zimmer Biomet: Large Joint Leader
Just over a month after saying it was going public again, Biomet Inc. is now to be acquired by number-three orthopedic player Zimmer Holdings Inc. for $13.35 billion in a combination of cash and stock. The purchase looks set to catapult Zimmer to the number-two position in the orthopedics market.
You may also be interested in...
The warning letter referred to CAPA and quality assurance issues at a surgical instruments manufacturing plant in China.
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.